Thursday, Dec. 22, 2022

 Thursday, Dec. 22, 2022, was a miserable day for the market as a whole. But Paradigm Press Group’s science-and-wealth specialist Ray Blanco noticed something interesting: “I saw plenty of relative strength in the SPDR S&P Biotech ETF (NYSE: XBI).

“Around noon, XBI was able to reverse off its losses and climb to just around breakeven.



Comments

Popular posts from this blog

Higher interest rates not lowering interest rates

Fed will not bring down inflation

Regional Banks